ClinicalTrials.gg
Drug

Perflutren clinical trials

Also written Definity and Octafluoropropane.

studies test it
63
open now
15
in phase 3
10
first study started
2004

How each study uses perflutren is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the perflutren studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Jul 2001 · DEFINITY · NDA 021064 (FDA, Drugs@FDA)
European Union
17 May 1998 · Optison · EMEA/H/C/000166 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Perflutren Lipid Microsphere
18
Perflutren Lipid Microspheres
11
NH002 (Perflutren Lipid Microspheres) Injectable Suspension
4
Microbubble contrast agent
4
Perflutren
4

Brand

Definity
49

Other names

Octafluoropropane
2
Perfluoropropane
1

Studies by the year they started

62 studies that test it; most in 2020 (7); 1 more planned to start later

Studies that test perflutren, by start year
YearStudies
20041
20051
20061
20072
20082
20092
20112
20124
20134
20145
20164
20174
20184
20193
20207
20211
20224
20232
20243
20252
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
15
Phase 2
17
Phase 3
10
Phase 4
8
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 54

Thomas Jefferson University (9) · Sunnybrook Health Sciences Centre (6) · UNC Lineberger Comprehensive Cancer Center (5) · Lantheus Medical Imaging (5) · Sidney Kimmel Cancer Center at Thomas Jefferson University (4) · Mayo Clinic (4) · Trust Bio-sonics, Inc. (3) · University of Southern California (3)

Often tested with

Tested in the same studies.

Sulfur Hexafluoride (4) · FS 069 (2) · Tissue Plasminogen Activator (1) · Irinotecan sucrosofate (1) · Irinotecan (1) · Fluorouracil (1) · Leucovorin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 3 in phase 3

Studies that test perflutren, phase 3 first.

Studies

Open first, then newest update. How each study uses perflutren is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 63

See all 63 studies that test perflutren →

Given beside what is tested · 4 — perflutren is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with perflutren

Codes

What other systems call perflutren · ClinicalTrials.gg INT003166

  • MeSH (NLM) C042852perflutrenConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) CK0N3WH0SRPERFLUTRENConfirmed FDA, NLM
  • RxNorm 283753One source FDA
  • NCI Thesaurus C47664PerflutrenOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.